Fidelity Investments
OLMA icon

Fidelity Investments’s Olema Pharmaceuticals OLMA Stock Holding History

Fidelity Investments’s Portfolio OLMA Stock Details OLMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$98.9M Sell
11,449,429
-693,633
-6% -$7.56M ﹤0.01% 1224
2026
Q2 		$152M Buy
12,143,062
+1,756,217
+17% +$23.5M 0.01% 1051
2026
Q1 		$155M Buy
10,386,845
+5,363,753
+107% +$119M 0.01% 977
2025
Q4 		$126M Buy
5,023,092
+4,993,670
+16,973% +$88.9M 0.01% 1072
2025
Q3 		$288K Buy
29,422
+1,181
+4% +$7.09K ﹤0.01% 3228
2025
Q2 		$120K Buy
28,241
+26,426
+1,456% +$118K ﹤0.01% 3529
2025
Q1 		$6.82K Sell
1,815
-44,013
-96% -$221K ﹤0.01% 4609
2024
Q4 		$267K Buy
45,828
+43,927
+2,311% +$439K ﹤0.01% 3160
2024
Q3 		$22.7K Buy
1,901
+865
+83% +$11.1K ﹤0.01% 4122
2024
Q2 		$11.2K Buy
1,036
+40
+4% +$434 ﹤0.01% 4295
2024
Q1 		$11.3K Buy
996
+88
+10% +$1.14K ﹤0.01% 4231
2023
Q4 		$12.7K Sell
908
-728
-44% -$9.8K ﹤0.01% 4160
2023
Q3 		$20.2K Buy
1,636
+972
+146% +$9.9K ﹤0.01% 3796
2023
Q2 		$6K Sell
664
-8
-1% -$48 ﹤0.01% 4309
2023
Q1 		$2.33K Sell
672
-24
-3% -$98 ﹤0.01% 4591
2022
Q4 		$1.71K Buy
696
+342
+97% +$997 ﹤0.01% 4551
2022
Q3 		$977 Sell
354
-3,579
-91% -$15.2K ﹤0.01% 4705
2022
Q2 		$16K Sell
3,933
-104,712
-96% -$332K ﹤0.01% 3964
2022
Q1 		$463K Sell
108,645
-454,209
-81% -$2.5M ﹤0.01% 3010
2021
Q4 		$5.27M Sell
562,854
-44,197
-7% -$916K ﹤0.01% 2351
2021
Q3 		$16.7M Sell
607,051
-35,700
-6% -$964K ﹤0.01% 1924
2021
Q2 		$18M Sell
642,751
-9,946
-2% -$283K ﹤0.01% 1886
2021
Q1 		$21.7M Sell
652,697
-1,800
-0.3% -$77.1K ﹤0.01% 1772
2020
Q4 		$31.5M Buy
+654,497
New +$30.7M ﹤0.01% 1509

Other funds holding OLMA

BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.23B AUM 121.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Lightspeed Management Company
Lightspeed Management Company Menlo Park, California $2.03B AUM 10.68% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM

Fidelity Investments's OLMA Position: Q3 2026 in Review

Fidelity Investments reduced its Olema Pharmaceuticals (OLMA) stake by 5.7% in Q3 2026, selling an estimated $7.56M and leaving 11,449,429 shares worth $98.9M. The position accounts for ﹤0.01% of the portfolio, ranked #1224.

Fidelity Investments first reported a position in OLMA in Q4 2020 and has held it in 24 quarters since. The position peaked at $155M in Q1 2026. 124 funds tracked by Wall St. Rank hold OLMA as of Q3 2026.

  • Fidelity Investments held 11,449,429 shares of Olema Pharmaceuticals worth $98.9M as of Q3 2026.
  • Fidelity Investments sold 693,633 Olema Pharmaceuticals shares in Q3 2026, an estimated $7.56M.
  • Olema Pharmaceuticals made up ﹤0.01% of Fidelity Investments's portfolio in Q3 2026, its #1224 holding.
  • Fidelity Investments first reported a position in Olema Pharmaceuticals in Q4 2020 and has held it in 24 quarters since.
  • Fidelity Investments's Olema Pharmaceuticals position peaked at $155M in Q1 2026.
  • 124 funds tracked by Wall St. Rank held Olema Pharmaceuticals as of Q3 2026.

Based on Fidelity Investments's 13F filing for Q3 2026, filed 10 Nov 2026.